HIV Non-Occupational Post-Exposure Prophylaxis

NCT01855867 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Single Dose Elivitegravir (150mg), Combicistat (150mg), Emtricitabine (200mg), Tenofovir DF (300mg)

Sponsor

Kenneth H. Mayer, MD

Collaborators

[object Object]